before and after glp 1 GLP-1 Weight Loss GLP-1 - Weight Loss Before
Description
Am J Hypertens 27(1):130139 Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, Simpson JA, Drucker DJ (2013) GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

This helps to maintain the quality and efficacy of GLP-1 medicines
37 STEP-HFpEF DM specifically investigated the effect of once-weekly subcutaneous semaglutide versus placebo on the primary endpoint of change in KCCQ-CSS at 52 weeks

An increase in side effects occurred with increased dosages

How Do They Compare
This is because pharma and biotech companies are lining up to contend for a slice of a projected $150 billion weight loss market, with more than 100 ongoing trials focused on Type 2 diabetes, obesity and a range of other diseases
